In March 2025, the company announced new designs for the immediate-to-shopper offering of its Wegovy weight loss drug. The company established a different pharmacy, called NovoCare, which would cost prospects $499 a month for use of the drug, under fifty percent the cost of the drug by other pharmaceutical distribution networks.[fifty three]Particu

In March 2025, the company introduced new programs for just a immediate-to-customer supplying of its Wegovy weight loss drug. The company recognized a brand new pharmacy, referred to as NovoCare, which would charge consumers $499 every month for usage of the drug, lower than fifty percent the price of the drug as a result of other pharmaceutical di